7 Jan 2020 11:32
Director/PDMR Shareholding
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES
January 7, 2020
Royal Dutch Shell plc (the “Company”) announces that on January 2, 2020, Wael Sawan, a Person Discharging Managerial Responsibilities (“PDMR”), acquired shares through participation in the Company’s Global Employee Share Purchase plan (“GESPP” or the “Plan”) in 2019. His contributions to GESPP prior to becoming a PDMR on July 1, 2019, were automatically used to purchase shares in accordance with the Rules of the Plan. Details of the number of shares and price are set out below.
This notification is made in accordance with Article 19 of the EU Market Abuse Regulation.
| 1. Details of the person discharging managerial responsibilities/person closely associated | |
| First Name(s) | Wael |
| Last Name(s) | Sawan |
| 2. Reason for the notification | |
| Position/status | Upstream Director |
| Initial notification/amendments | Initial notification |
| 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
| Full name of the entity | Royal Dutch Shell plc |
| Legal Entity Identifier code | 21380068P1DRHMJ8KU70 |
| 4. Details of the transaction(s) section to be repeated for (i) each type of instrument, (ii) each type of transaction, (iii) each date, (iv) each place where transactions have been conducted | |
| Description of the financial instrument | A Ordinary shares |
| Identification Code | GB00B03MLX29 |
| Nature of the transaction | Purchase of shares |
| Currency | EURO |
| Price | €22.06 |
| Volume | 147 |
| Total | €3,242.82 |
| Aggregated information VolumePrice Total | 147€22.06€3,242.82 |
| Date of transaction | January 2, 2020 |
| Place of transaction | Amsterdam |
Anthony Clarke Deputy Company Secretary
ENQUIRIES
Shell Media RelationsInternational, UK, European Press: +44 20 7934 5550Shell Investor RelationsEurope: +31 70 377 4540United States: +1 832 337 2034